Last checked at 8 Sep 2020 19:32
IN BRIEF: Synairgen Reports Promising Findings From SNG001 Trial
IN BRIEF: Synairgen Reports Promising Findings From SNG001 Trial
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Synairgen Share News (SNG)
SNG Share
Price
SNG Share
News
SNG Share
Chat5
SNG Share
Trades9
SNG
Live RNS
SNG Share
Charts
SNG Level 2
Console
SNG Live
Share Price
SNG Broker
Ratings
SNG Directors
Deals
SNG Financial
Diary
SNG
Fundamentals
SNG Short
Positions
SNG
Media
Synairgen Information
Share Price Information for Synairgen (SNG)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
6.59
Bid:
6.00
Ask:
7.18
Change:
0.00 (0.00%)
Spread:
1.18 (19.667%)
Open:
6.59
High:
0.00
Low:
0.00
Prev. Close:
6.59
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.8 Sep 2020 15:16
Synairgen upbeat on latest data from SNG001 trials
(Sharecast News) - Respiratory drug discovery and development company Synairgen announced positive data from the interim analysis of its exploratory phase 2 clinical trial of inhaled 'SNG001' on Tuesday, in chronic obstructive pulmonary disease (COPD) patients with a confirmed respiratory viral infection.
Read more21 Jul 2020 15:51
IN BRIEF: Synairgen Moving "Rapidly" To Get SNG001 Over Line
IN BRIEF: Synairgen Moving "Rapidly" To Get SNG001 Over Line
Read more20 Jul 2020 20:23
COVID SCIENCE-Multiple vaccine candidates show early promise; inhaled interferon helps severe COVID-19 patients
By Nancy LapidJuly 20 (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Early tests of COVID-19 ...
Read more20 Jul 2020 16:55
LONDON MARKET CLOSE: FTSE 100 Lags Despite Encouraging Vaccine News
LONDON MARKET CLOSE: FTSE 100 Lags Despite Encouraging Vaccine News
Read more20 Jul 2020 11:54
Synairgen Shares Soar On Positive Trial Results For Covid-19 Treatment
Synairgen Shares Soar On Positive Trial Results For Covid-19 Treatment
Read more20 Jul 2020 09:10
REFILE-UPDATE 2-Synairgen soars after drug shows promise in COVID-19 cases
(Refiles to correct spelling in the media identifier)* Shares hit all-time high on Monday* Company's drug cuts risk of severe COVID-19 by 79%* Some researchers caution on enthusiasmBy Aakash BJuly 20 (Reuters) - Synairgen shares rose almost sixfold ...
Read more20 Jul 2020 09:10
UPDATE 2-Synairgen soars after drug shows promise in COVID-19 cases
* Shares hit all-time high on Monday* Company's drug cuts risk of severe COVID-19 by 79%* Some researchers caution on enthusiasm (Recasts, adds comment from CEO and academic expert)By Aakash BJuly 20 (Reuters) - Synairgen shares rose almost sixfold...
Read more20 Jul 2020 09:10
UPDATE 1-Synairgen shares soar as drug shows lower risk of severe COVID-19 cases
(Adds details on the trial, shares)July 20 (Reuters) - Synairgen Plc said on Monday its drug helped reduce the risk of severe cases in hospitalised patients with COVID-19, according to data from a trial of more than 100 people in the United Kingdo...
Read more20 Jul 2020 07:56
Europe open: Stocks reverse early losses, healthcare leads
(Sharecast News) - Stocks have recovered from early selling following news that European Union leaders meeting in Brussels had made progress on the terms for a reconstruction fund.
Read more20 Jul 2020 07:56
Synairgen's drug shows reduced risk of severe disease in COVID-19 patients
July 20 (Reuters) - Synairgen Plc said on Monday its drug helped reduce the risk of developing severe diseases in hospitalised COVID-19 patients, according to data from a trial of more than 100 people in the United Kingdom.The trial, which used in...
Read more20 Jul 2020 07:20
Synairgen treatment reduces risk of 'severe' Covid-19 by 79%
(Sharecast News) - Synairgen's Covid-19 treatment sharply reduced the risk of patients developing severe forms of the illness provoked by the novel coronavirus, clinical trials showed.
Read more22 Jun 2020 16:09
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more18 Jun 2020 17:59
IN BRIEF: Synairgen Expands Home Setting Trial Of Inhaled SNG001
IN BRIEF: Synairgen Expands Home Setting Trial Of Inhaled SNG001
Read more18 Jun 2020 09:12
Synairgen expands Covid-19 trial nationwide
(Sharecast News) - Synairgen is to expand trials of a potential treatment for Covid-19 nationally, the respiratory drug specialist said on Thursday.
Read more